WASHINGTON, D.C. — November 10, 2015 — The Sabin Vaccine Institute (Sabin) today announced that Regina Rabinovich, M.D., M.P.H., has joined its Board of Trustees. Dr. Rabinovich is the ExxonMobil Malaria Scholar in Residence at the Harvard T.H. Chan School of Public Health and Global Health Institute. In addition, Dr. Rabinovich is chair of the Malaria Eradication Scientific Alliance at ISGlobal, University of Barcelona, where she also serves as director of the Malaria Elimination Initiative and senior advisor for the Chagas Initiative.

"Dr. Rabinovich is a recognized global health leader whose 25 years of experience in health and philanthropic sectors will be an exceptional asset to Sabin as we advance our programs to address vaccine-preventable and neglected tropical diseases," said Dr. Axel Hoos, interim chairman of the Sabin Board of Trustees. "Her expertise and experience will help guide Sabin as we assess new opportunities to leverage our strengths in advocacy, communications and vaccine product development."

Prior to joining Harvard, Dr. Rabinovich spent nearly a decade as director of the infectious diseases division at the Bill & Melinda Gates Foundation, overseeing the development and implementation of strategies for prevention, treatment and control programs. She also held senior positions at the U.S. National Institute of Allergy and Infectious Diseases, and previously served as director of the PATH Malaria Vaccine Initiative.

"I welcome the opportunity to support Sabin’s mission to reduce needless human suffering through the development of new vaccines, advocacy for increased use of existing vaccines, and promotion of expanded access to affordable medical treatments," said Dr. Rabinovich. "Having worked on infectious and tropical diseases for many years, I hope to provide valuable guidance to Sabin as it continues to champion and develop low-cost, highly effective health solutions on behalf of the world’s poorest communities."

Dr. Rabinovich also serves on the boards of AERAS, a non-profit biotech focused on developing vaccines for tuberculosis, and the Catholic Medical Mission Board.


About the Sabin Vaccine Institute

The Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization of scientists, researchers and advocates dedicated to reducing needless human suffering from vaccine-preventable and neglected tropical diseases (NTDs). Since its founding in 1993 in honor of Dr. Albert B. Sabin, the developer of the oral polio vaccine, Sabin has been at the forefront of global efforts to eliminate, prevent, and cure infectious and neglected tropical diseases.

Sabin develops new vaccines, advocates for increased use of existing vaccines and promotes expanded access to affordable medical treatments in collaboration with governments, academic institutions, scientists, medical professionals and other non-profit organizations. For more information, please visit www.sabin.org.

Media Contact
Kelly Toves
+1 (202) 621-1691